Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.520 | 4.740 | 0.220 |
Shares | 95.480 | 95.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.039 | 19.734 |
Price to Book | 4.133 | 3.904 |
Price to Sales | 6.110 | 5.520 |
Price to Cash Flow | 15.195 | 15.057 |
Dividend Yield | 0.725 | 0.495 |
5 Years Earnings Growth | 38.801 | 31.412 |
Number of long holdings: 93
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 8.37 | 408.18 | +0.72% | |
Gilead | US3755581036 | 7.98 | 93.95 | +0.59% | |
Amgen | US0311621009 | 7.98 | 264.49 | +0.19% | |
Regeneron Pharma | US75886F1075 | 5.26 | 714.47 | -0.09% | |
Alnylam | US02043Q1076 | 4.40 | 243.25 | +0.41% | |
AstraZeneca ADR | US0463531089 | 3.48 | 66.30 | -0.50% | |
Insmed | US4576693075 | 3.46 | 70.53 | -0.08% | |
Illumina | US4523271090 | 2.39 | 135.21 | +0.16% | |
Biogen | US09062X1037 | 1.98 | 149.02 | -0.24% | |
Ultragenyx | US90400D1081 | 1.95 | 43.75 | -0.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Kapital Plus P2 EUR | 4.68M | 3.65 | -0.38 | 3.30 | ||
Kapital Plus I EUR | 89.69M | 0.97 | -1.66 | 2.84 | ||
Kapital Plus P EUR | 7.58M | 0.97 | -1.66 | 2.79 | ||
DE000A2DU1Y2 | 18.69M | 0.09 | -2.70 | 1.76 | ||
Kapital Plus A EUR | 2.86B | 1.42 | -2.11 | 2.19 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review